Hyperglycemia in HR+ Breast Cancer: Prevention and Management Strategies for Oncology Pharmacists

Source: Pharmacy Times articles

Hyperglycemia is a common and significant adverse effect of PI3K and AKT inhibitors in hormone receptor-positive (HR+) breast cancer.
Read More